|
2025
|
Invention
|
Direct resolution of desacetylketoconazole salt. The invention relates to novel achiral organic o... |
|
2023
|
Invention
|
Novel salt of substituted 5-fluoro-1h-pyrazolopyridines and its uses. Hbb] pyridine-3-carboximida... |
|
2022
|
Invention
|
Combination of omzotirome and antidiabetic agent, antihypertensive agent or anti-dyslipidemic age... |
|
|
Invention
|
Stable pharmaceutical liquid composition of nilotinib. The present invention relates to the pharm... |
|
|
Invention
|
In-situ synthesis of 3-substituted pyridinium compounds. Present invention relates to an in-situ ... |
|
2019
|
Invention
|
Methods of producing pyrazole compounds. The present invention is directed to methods of producin... |
|
|
Invention
|
Pyridinium compounds. The present invention relates to novel pyridinium compounds, their isomers,... |
|
2018
|
Invention
|
Compounds with beta-adrenergic agonist and antimuscarinic activity. The present invention relates... |
|
|
Invention
|
Intranasal composition of methylcobalamin. The present invention relates to an intranasal composi... |
|
|
Invention
|
Tapentadol nasal composition. An intranasal composition as unit dosage, comprising tapentadol or ... |
|
|
Invention
|
Tapentadol nasal composition. Disclosed herein are pharmaceutical compositions for nasal administ... |
|
|
Invention
|
Fused imidazobenzothiazole compounds. The present invention relates to novel fused Imidazobenzoth... |
|
2017
|
Invention
|
Novel indazole compounds. The present invention relates to substituted indazole compounds, their ... |
|
|
Invention
|
Topical compositions of apremilast.
The present invention relates to topical pharmaceutical comp... |
|
|
Invention
|
Topical compositions of apremilast. The present invention relates to topical pharmaceutical compo... |
|
|
Invention
|
Substituted fused pyrimidinone compounds.
Provided herein are novel fused pyrimidinone derivativ... |
|
|
Invention
|
Substituted fused pyrimidinone compounds. Provided herein are novel fused pyrimidinone derivative... |
|
|
Invention
|
Low dose pharmaceutical composition. Present invention relates to a low dose pharmaceutical compo... |
|
2016
|
Invention
|
Pharmaceutical composition of alogliptin and metformin. Present invention relates to a stable pha... |
|
|
Invention
|
Pharmaceutical formulations. This invention relates to pharmaceutical formulations comprising 1-(... |
|
|
Invention
|
Novel pyridinium compounds. The present invention relates to novel pyridinium compounds, their is... |
|
2015
|
Invention
|
Urea-substituted indanes as p38 map kinase inhibitors. The present invention relates to novel ind... |
|
|
Invention
|
P38 map kinase inhibiting indanyl urea compounds. The present application relates to p38 MAPK inh... |
|
|
Invention
|
Stable solifenacin composition. The present invention provides a stable solid oral pharmaceutical... |
|
|
Invention
|
Novel fused imidazobenzothiazole compounds. The present invention relates to novel fused Imidazob... |
|
|
Invention
|
Pharmaceutical composition of roflumilast. Present invention relates to multiparticulate pharmace... |
|
|
Invention
|
Pharmaceutical composition of fingolimod. Present invention relates to a solid oral composition c... |
|
2014
|
Invention
|
Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel disease. Present invention... |
|
2013
|
Invention
|
Fused thiazolo and oxazolo pyrimidinones. The present invention relates to novel compounds, their... |
|
2012
|
Invention
|
Pharmaceutical composition of tapentadol for parenteral administration. The present invention rel... |
|
|
Invention
|
Novel substituted imidazopyrimidines as gpbar1 receptor modulators.
The present invention relate... |
|
|
Invention
|
Novel substituted imidazopyrimidines as gpbar1 receptor modulators. The present invention relates... |
|
|
Invention
|
Pharmaceutical composition of tapentadol for nasal administration. The present invention relates ... |
|
|
Invention
|
Pharmaceutical invention of tapentadol. The present invention relates to a pharmaceutical composi... |
|
|
Invention
|
Acid addition salt of donepezil and pharmaceutical composition thereof.
Disclosed is an acid add... |
|
|
Invention
|
Acid addition salt of donepezil and pharmaceutical composition thereof. Disclosed is an acid addi... |
|
|
Invention
|
Acid addition salts of risperidone and pharmaceutical compositions thereof. The present invention... |
|
|
Invention
|
Pyrazole-based thyroid receptor compounds. 4 and Z are as defined in the specification, method fo... |
|
2011
|
Invention
|
Pharmaceutical composition containing goserelin for in-situ implant. The present invention provid... |
|
|
Invention
|
Sustained release oral liquid suspension dosage form. A ready to use stable, sustained release or... |
|
2010
|
Invention
|
Sustained release pharmaceutical composition of quetiapine and process for preparation thereof.
... |
|
2004
|
P/S
|
House mark for a full line of pharmaceuticals except veterinary preparations |